U.S. Markets open in 4 hrs 50 mins
  • S&P Futures

    3,776.50
    -44.75 (-1.17%)
     
  • Dow Futures

    30,704.00
    -295.00 (-0.95%)
     
  • Nasdaq Futures

    11,527.25
    -163.75 (-1.40%)
     
  • Russell 2000 Futures

    1,699.70
    -21.70 (-1.26%)
     
  • Crude Oil

    110.00
    +0.22 (+0.20%)
     
  • Gold

    1,815.10
    -2.40 (-0.13%)
     
  • Silver

    20.66
    -0.08 (-0.40%)
     
  • EUR/USD

    1.0457
    +0.0013 (+0.1255%)
     
  • 10-Yr Bond

    3.0930
    0.0000 (0.00%)
     
  • Vix

    29.31
    +0.95 (+3.35%)
     
  • GBP/USD

    1.2157
    +0.0034 (+0.2845%)
     
  • USD/JPY

    136.3260
    -0.2190 (-0.1604%)
     
  • BTC-USD

    19,314.47
    -765.20 (-3.81%)
     
  • CMC Crypto 200

    414.88
    -24.78 (-5.64%)
     
  • FTSE 100

    7,187.62
    -124.70 (-1.71%)
     
  • Nikkei 225

    26,393.04
    -411.56 (-1.54%)
     

Global Vagus Nerve Stimulators Market to Surpass US$ 1,251.9 Million by 2030 - Coherent Market Insights

·4 min read

SEATTLE, June 6, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global vagus nerve stimulators market is estimated to be valued at US$  628.3 million in 2022 and is expected to exhibit a CAGR of 9.0% over the forecast period (2022-2030).

Coherent Market Research Logo
Coherent Market Research Logo

Key Trends and Analysis of the Global Vagus Nerve Stimulators Market:

Key trends in the market include increasing prevalence of neurological disorders such as epilepsy, depression, anxiety, migraine, among others; increasing approval of novel products, and increasing collaborations, acquisitions, and partnerships among key players. These key trends are expected to aid in growth of the global vagus nerve stimulators market.

According to an article published by The Scientific World Journal, a peer-reviewed, open access journal, in June 2020, it is estimated that migraine prevalence ranged between 2.6% and 32% among the general population in Arab countries (such as Bahrain, Iraq, Jordan, etc.), in 2019. The same source also estimates that the prevalence of migraine headache among school children of age group 6 to 18 years ranged between 7.1% and 13.7% and between 12.2% and 27.9% in medical university students in Arab countries in 2019.

Moreover, increasing approvals of novel vagus nerve stimulator products are expected to drive the market growth over the forecast period. For instance, in January 2022, electroCore, Inc., a U.S. based medical technology company announced that it has received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its gammaCore Non-Invasive Vagus Nerve Stimulation(nVNS) for the treatment of post-traumatic stress disorder (PTSD).

Furthermore, key players operating in the global vagus nerve stimulators market are focusing on adoption of inorganic growth strategies such as distributor agreements, acquisitions, collaborations, in order to expand their market presence in the global market. For instance, in February 2021, electroCore, Inc. announced that it has entered into a distributive agreement with Medistar, an Australia based independent medical device distributor, distribution of electroCore, Inc.'s gammaCore Sapphire non-invasive vagus nerve stimulator (nVNS) in Australia.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2514

Key Market Takeaways:

The global vagus nerve stimulators market is expected to exhibit a CAGR of 5.1% over the forecast period, owing to rising research in development of novel vagus nerve stimulators. For instance, in February 2021, SetPoint Medical, a U.S. based biotechnology company announced that it has enrolled the first patient in its Investigational Device Exemption (IDE) study, which aims to evaluate SetPoint's proprietary bioelectronics device, a vagus nerve stimulator for treatment of rheumatoid arthritis.

Among applications, epilepsy segment is expected to account for the largest market share in 2022, owing to high incidence of epilepsy. For instance, according to data published by the World Health Organization (WHO) in February 2022, it was estimated that epilepsy is the most common neurological disease in the world, with around 50 million people suffering from epilepsy, globally, in 2019.

Key players operating in the global vagus nerve stimulators market include LivaNova PLC, electroCore, Inc., SetPoint Medical Corporation, Beijing PINS Medical Co., Ltd., Parasym Ltd., Nervana, LLC, tVNS Technologies GmbH, BioControl Medical, NeurAxis, Inc., Soterix Medical Inc., MicroTransponder Inc., Boston Scientific Corporation, Cyberonics, Inc., EnteroMedics Inc., ReShape Lifesciences Inc., and Cerbomed GmbH etc.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2514

Detailed Segmentation:

Global Vagus Nerve Stimulators Market, By Product Type:

  • Implantable Devices

  • External Devices

Global Vagus Nerve Stimulators Market, By Application:

  • Epilepsy

  • Depression & Anxiety

  • Cluster Headache & Migraine

  • Others (Crohn's disease, Dyskinesia, among others)

Global Vagus Nerve Stimulators Market, By End User:

  • Hospitals

  • Specialty Clinics

  • Others (Research Institutions, Ambulatory Surgical Centers, among others)

Global Vagus Nerve Stimulators Market, By Region:

  • North America

  • Europe     

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/2514

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah 
Senior Client Partner – Business Development 
Coherent Market Insights 
Phone: 
US: +1-206-701-6702 
UK: +44-020-8133-4027 
Japan: +81-050-5539-1737 
India: +91-848-285-0837 
Email: sales@coherentmarketinsights.com  
Website: https://www.coherentmarketinsights.com 
Follow Us: LinkedInTwitter 

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/global-vagus-nerve-stimulators-market-to-surpass-us-1-251-9-million-by-2030--coherent-market-insights-301561647.html

SOURCE Coherent Market Insights